Indication
Anti-CD20 Therapy
1 clinical trial
1 product
Clinical trial
COVID-19 Infection in Patients Receiving Anti-CD20 Therapy: Clinical Course and Convalescent Plasma TherapyStatus: Completed, Estimated PCD: 2023-01-15
Product
Convalescent Plasma